Juanjuan Dai

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Monoclonal Antibody

Radiation Induced

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Juanjuan Dai, Junmeng Zhu, Lijing Zhu, Xiaolu Wang, Jinfeng Bao, Xinjie Chen, Yingling Zhou, Limei Min, Haoyue Qi, Qin Liu, Jie Shen, Manman Tian, Jie Shao, Rutian Li, Baorui Liu
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: 'R-ISV-FOLactis' trial. Future oncology (London, England) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)